Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndromeNoriko Miyake, Naomichi Matsumoto, Eiichi Arai et al.|Human Mutation|2010Cited by 158
A new Ehlers–Danlos syndrome with craniofacial characteristics, multiple congenital contractures, progressive joint and skin laxity, and multisystem fragility‐related manifestationsTomoki Kosho, Naomichi Matsumoto, Noriko Miyake et al.|American Journal of Medical Genetics Part A|2010Cited by 88
10P Phase I study of magrolimab (ONO-7913) and nivolumab (ONO-4538, NIV) in combination with FOLFOX and bevacizumab (Bev) or cetuximab (Cet) as first-line treatment in patients with unresectable advanced or recurrent colorectal cancer (CRC)K. Yamaguchi, T. Yoshino, A. Takashima et al.|Annals of Oncology|2025Cited by 2